The population pharmacokinetics of theophylline in neonates and young infants (Q41307855)

29 September 2017

title

The population pharmacokinetics of theophylline in neonates and young infants (English)

1 reference

29 September 2017

1 reference

E S Moore

1 reference

29 September 2017

R G Faix

series ordinal

1 reference

29 September 2017

R C Banagale

series ordinal

1 reference

29 September 2017

T H Grasela

series ordinal

1 reference

29 September 2017

publication date

1 February 1989

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

29 September 2017

published in

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

47-66

1 reference

Neonatal apnea: pathogenesis and therapy

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Apnea in newborn infants: Approach to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Pharmacokinetic aspects of theophylline in premature newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Theophylline pharmacokinetics in premature infants with apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Plasma xanthine levels in low birthweight infants treated or not treated with theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Interconversion of theophylline and caffeine in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Conjugated hyperbilirubinemia in infancy associated with parenteral alimentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Decreased theophylline half-life in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Controlled clinical trial of phenobarbital and-or light in reducing neonatal hyperbilirubinemia in a predominantly Negro population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Enzyme induction (first of three parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Pharmacokinetic Drug Interactions with Theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059087

Absolute bioavailability of oral theophylline

21 January 2018

1 reference

12 December 2020

Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn

1 reference

12 December 2020

Adverse effects of caffeine and theophylline in the newborn infant

1 reference

12 December 2020

Factors influencing theophylline disposition in 179 newborns

1 reference

12 December 2020

Postnatal development of theophylline metabolism in preterm infants

1 reference

12 December 2020

The influence of cigarette smoking and sex on theophylline disposition

1 reference

12 December 2020

Dose-dependent kinetics of theophylline disposition in asthmatic children

1 reference

12 December 2020

Theophylline pharmacokinetics in the young infant

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacologic considerations in the therapy of neonatal apnea

1 reference

12 December 2020

Interaction between nutrition and theophylline metabolism in children

1 reference

12 December 2020

Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data

1 reference

12 December 2020

Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life

1 reference

12 December 2020

The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole

1 reference

12 December 2020

Phenobarbitone prophylaxis for neonatal hyperbilirubinemia

1 reference

12 December 2020

A simplified score for assessment of fetal maturation of newly born infants

1 reference

12 December 2020

Factors affecting theophylline pharmacokinetics in premature infants with apnea

1 reference

12 December 2020

Effect of phenobarbital on theophylline disposition

1 reference

12 December 2020

Effect of asphyxia on theophylline clearance in newborns

1 reference

12 December 2020

Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature

1 reference

12 December 2020

Methods of intravenous drug administration in the pediatric patient

1 reference

12 December 2020

Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery

1 reference

12 December 2020

Theophylline disposition in infancy

1 reference

12 December 2020

An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies

1 reference

12 December 2020

Enhanced biotransformation of theophylline in marihuana and tobacco smokers

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01059087

1 reference

29 September 2017

1 reference